Literature DB >> 10666126

Hypoxia induces hexokinase II gene expression in human lung cell line A549.

S R Riddle1, A Ahmad, S Ahmad, S S Deeb, M Malkki, B K Schneider, C B Allen, C W White.   

Abstract

During adaptation to hypoxic and hyperoxic conditions, the genes involved in glucose metabolism are upregulated. To probe involvement of the transcription factor hypoxia-induced factor-1 (HIF-1) in hexokinase (HK) II expression in human pulmonary cells, A549 cells and small-airway epithelial cells (SAECs) were exposed to stimuli such as hypoxia, deferoxamine (DFO), and metal ions. The largest increase in HK-II (20-fold for mRNA and 2.5-fold for enzymatic activity) was observed in A549 cells when exposed to DFO. All stimuli selectively increased the 5.5-kb rather than 4-kb transcript in A549 cells. Cycloheximide and actinomycin D inhibited these responses. In addition, cells were transfected with luciferase reporter constructs driven by the full-length HK-II 5'-regulatory region (4.0 kb) or various deletions of that region. A549 cells transfected with the 4.0-kb construct and exposed to hypoxia or DFO increased their luciferase activity 7- and 10-fold, respectively, indicating that HK-II induction is, at least in part, due to increased gene transcription. Sixty percent of the inducible activity of the 4.0-kb construct was shown to reside within the proximal 0.5 kb. Additionally, cotransfection with a stable HIF-1 mutant and the 4.0-kb promoter construct resulted in increased luciferase activity under normoxic conditions. These results strongly suggest that HK-II is selectively regulated in pulmonary cells by a HIF-1-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666126     DOI: 10.1152/ajplung.2000.278.2.L407

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  46 in total

Review 1.  Use of positron emission tomography in anticancer drug development.

Authors:  Eric O Aboagye; Patricia M Price
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

2.  Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells.

Authors:  Ulrike Olszewski; Robert Zeillinger; Klaus Geissler; Gerhard Hamilton
Journal:  Lung Cancer (Auckl)       Date:  2010-09-04

3.  Expression and role in glycolysis of human ADP-dependent glucokinase.

Authors:  Susan Richter; Jan P Richter; Sunali Y Mehta; Amanda M Gribble; Andrew J Sutherland-Smith; Kathryn M Stowell; Cristin G Print; Ron S Ronimus; William R Wilson
Journal:  Mol Cell Biochem       Date:  2012-01-05       Impact factor: 3.396

4.  Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.

Authors:  Grace Guzman; Rohini Chennuri; Alexander Chan; Bryan Rea; Ada Quintana; Roshan Patel; Pei-Zhang Xu; Hui Xie; Nissim Hay
Journal:  Dig Dis Sci       Date:  2014-11-08       Impact factor: 3.199

Review 5.  HIF1α and metabolic reprogramming in inflammation.

Authors:  Sarah E Corcoran; Luke A J O'Neill
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

6.  Conserved principles of mammalian transcriptional regulation revealed by RNA half-life.

Authors:  Caroline C Friedel; Lars Dölken; Zsolt Ruzsics; Ulrich H Koszinowski; Ralf Zimmer
Journal:  Nucleic Acids Res       Date:  2009-06-26       Impact factor: 16.971

7.  Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury.

Authors:  Joshua A Smith; L Jay Stallons; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-02

Review 8.  Metabolic circuits in neural stem cells.

Authors:  Do-Yeon Kim; Inmoo Rhee; Jihye Paik
Journal:  Cell Mol Life Sci       Date:  2014-07-19       Impact factor: 9.261

9.  Sirtuin-3 modulates Bak- and Bax-dependent apoptosis.

Authors:  Manish Verma; Nataly Shulga; John G Pastorino
Journal:  J Cell Sci       Date:  2012-10-29       Impact factor: 5.285

Review 10.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.